Review: taking Metoprolol tartrate and Unisom together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Unisom together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Unisom. It is created by eHealthMe based on reports of 18 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol tartrate and Unisom >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 38,699 users)

Unisom

Unisom has active ingredients of doxylamine succinate. It is often used in insomnia. (latest outcomes from Unisom 1,158 users)

On Jul, 28, 2016

18 people who take Metoprolol Tartrate, Unisom are studied.


Number of reports submitted per year:

Metoprolol tartrate and Unisom drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Unisom:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 0.0% - (0 of 0 people)
  • male: 50.0% - (1 of 2 people)
Unisom:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Unisom:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • arteriosclerosis coronary artery
  • coronary artery insufficiency
  • death
1 - 2 years:
  • eye twitch
  • neuropathy
  • slurred speech
2 - 5 years:
  • eye twitch
  • neuropathy
  • slurred speech
not specified:
  • drug dependence
  • arthralgia
  • chest pain
  • diverticulum
  • drug abuser
  • drug toxicity
  • nausea
  • abdominal adhesions
  • abdominal distension
  • insomnia

Most common drug interactions by gender *:

female:
  • drug dependence
  • arthralgia
  • bradyphrenia
  • depression
  • feelings of worthlessness
  • fibromyalgia
  • foot deformity
  • insomnia
  • limb injury
  • lip disorder
male:
  • chest pain
  • diverticulum
  • insomnia
  • abdominal distension
  • angioedema
  • arteriosclerosis
  • arteriosclerosis coronary artery
  • arthralgia
  • carotid artery occlusion
  • chest discomfort

Most common drug interactions by age *:

30-39:
  • eye twitch
  • neuropathy
  • slurred speech
40-49:
  • abdominal adhesions
  • bradyphrenia
  • fibromyalgia
  • liver fatty
  • malaise
  • nausea
  • oedema lower limb
  • psoriasis
  • pulmonary congestion
  • renal cell carcinoma stage unspecified
50-59:
  • abdominal distension
  • angioedema
  • arteriosclerosis coronary artery
  • arthralgia
  • chest discomfort
  • chest pain
  • cold sweat
  • constipation
  • contusion
  • coronary artery insufficiency
60+:
  • drug dependence
  • arteriosclerosis
  • carotid artery occlusion
  • chest pain
  • cholelithiasis
  • dehydration
  • diverticulum
  • dysphagia
  • fall
  • feelings of worthlessness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Unisom?

Can you answer these questions?

More questions for: Metoprolol tartrate, Unisom

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Unisom

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Unisom (doxylamine succinate) is often used to treat insomnia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.